ACCORD HEALTHCARE LAUNCH PRASUGREL

Accord Healthcare is delighted to announce the launch of Prasugrel Accord 10 mg which is available in a pack size of 28 tablets.

This medicine, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndrome (i.e. unstable angina, non-ST segment elevation myocardial infarction [UA/NSTEMI] or ST segment elevation myocardial infarction [STEMI]) undergoing primary or delayed percutaneous coronary intervention (PCI).